- Home
- SNDL vs PRLD Comparison
SNDL vs PRLD Comparison
Compare SNDL & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNDL | PRLD |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 302.7M | 260.2M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SNDL | PRLD |
|---|---|---|
| Price | $1.29 | $3.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $3.48 | ★ $9.20 |
| AVG Volume (30 Days) | ★ 1.2M | 444.7K |
| Earning Date | 10-27-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,140,000.00 |
| Revenue This Year | N/A | $258.83 |
| Revenue Next Year | $1.68 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 73.43 |
| 52 Week Low | $1.13 | $1.17 |
| 52 Week High | $2.34 | $6.83 |
Technical Indicators
Market Signals| Indicator | SNDL | PRLD |
|---|---|---|
| Relative Strength Index (RSI) | 53.59 | 40.45 |
| Support Level | $1.17 | $3.48 |
| Resistance Level | $1.48 | $4.07 |
| Average True Range (ATR) | 0.05 | 0.25 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 91.67 | 47.06 |
Price Performance
Historical ComparisonAbout SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.